{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:22:42Z","timestamp":1773915762925,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diabetic cardiomyopathy (DCM) is defined as structural and functional changes in the myocardium due to metabolic and cellular abnormalities induced by diabetes mellitus (DM). The impact of prediabetic conditions on the cardiac tissue remains to be elucidated. The goal of this study was to elucidate whether cardiac dysfunction is already present in a state of prediabetes, in the presence of insulin resistance, and to unravel the underlying mechanisms, in a rat model without obesity and hypertension as confounding factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Two groups of 16-week-old Wistar rats were tested during a 9\u2009week protocol: high sucrose (HSu) diet group (n\u2009=\u20097) \u2013 rats receiving 35% of sucrose in drinking water vs the vehicle control group (n\u2009=\u20097). The animal model was characterized in terms of body weight (BW) and the glycemic, insulinemic and lipidic profiles. The following parameters were assessed to evaluate possible early cardiac alterations and underlying mechanisms: blood pressure, heart rate, heart and left ventricle (LV) trophism indexes, as well as the serum and tissue protein and\/or the mRNA expression of markers for fibrosis, hypertrophy, proliferation, apoptosis, angiogenesis, endothelial function, inflammation and oxidative stress.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The HSu-treated rats presented normal fasting plasma glucose (FPG) but impaired glucose tolerance (IGT), accompanied by hyperinsulinemia and insulin resistance (P\u2009&lt;\u20090.01), confirming this rat model as prediabetic. Furthermore, although hypertriglyceridemia (P\u2009&lt;\u20090.05) was observed, obesity and hypertension were absent. Regarding the impact of the HSu diet on the cardiac tissue, our results indicated that 9\u2009weeks of treatment might be associated with initial cardiac changes, as suggested by the increased LV weight\/BW ratio (P\u2009&lt;\u20090.01) and a remarkable brain natriuretic peptide (BNP) mRNA overexpression (P\u2009&lt;\u20090.01), together with a marked trend for an upregulation of other important mediators of fibrosis, hypertrophy, angiogenesis and endothelial lesions, as well as oxidative stress. The inflammatory and apoptotic markers measured were unchanged.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This animal model of prediabetes\/insulin resistance could be an important tool to evaluate the early cardiac impact of dysmetabolism (hyperinsulinemia and impaired glucose tolerance with fasting normoglycemia), without confounding factors such as obesity and hypertension. Left ventricle hypertrophy is already present and brain natriuretic peptide seems to be the best early marker for this condition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2840-12-44","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T21:30:41Z","timestamp":1362691841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker"],"prefix":"10.1186","volume":"12","author":[{"given":"Sara","family":"Nunes","sequence":"first","affiliation":[]},{"given":"Edna","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Viana","sequence":"additional","affiliation":[]},{"given":"Eug\u00e9nia","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Frederico C","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1vio","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"issue":"3","key":"618_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00592-010-0180-x","volume":"48","author":"R Tarquini","year":"2011","unstructured":"Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF: The diabetic cardiomyopathy. Acta Diabetol. 2011, 48 (3): 173-181. 10.1007\/s00592-010-0180-x.","journal-title":"Acta Diabetol"},{"issue":"4","key":"618_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004, 25 (4): 543-567. 10.1210\/er.2003-0012.","journal-title":"Endocr Rev"},{"issue":"Suppl 1","key":"618_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00019501-200511001-00002","volume":"16","author":"DN Tziakas","year":"2005","unstructured":"Tziakas DN, Chalikias GK, Kaski JC: Epidemiology of the diabetic heart. Coron Artery Dis. 2005, 16 (Suppl 1): S3-S10.","journal-title":"Coron Artery Dis"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.beem.2008.10.016","volume":"23","author":"K Khavandi","year":"2009","unstructured":"Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, Heagerty AM, Malik RA: Diabetic cardiomyopathy- a distinct disease?. Best Pract Res Clin Endocrinol Metab. 2009, 23: 347-360. 10.1016\/j.beem.2008.10.016.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","volume":"27","author":"MS Nieminen","year":"2006","unstructured":"Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L, EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology: EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006, 27: 2725-2736. 10.1093\/eurheartj\/ehl193.","journal-title":"Eur Heart J"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cardfail.2008.04.001","volume":"14","author":"A Cohen-Solal","year":"2008","unstructured":"Cohen-Solal A, Beauvais F, Loqeart D: Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Card Fail. 2008, 14: 615-625. 10.1016\/j.cardfail.2008.04.001.","journal-title":"J Card Fail"},{"issue":"5","key":"618_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/dmrr.1089","volume":"26","author":"H Wang","year":"2010","unstructured":"Wang H, Shara NM, Calhoun D, Umans JG, Lee ET, Howard BV: Incidence rates and predictors of diabetes in those with prediabetes: the strong heart study. Diabetes Metab Res Rev. 2010, 26 (5): 378-385. 10.1002\/dmrr.1089.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"618_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/archpediatrics.2009.268","volume":"164","author":"QM Nguyen","year":"2010","unstructured":"Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS: Fasting plasma glucose levels within the normoglycemic range in childhood as a predictor of prediabetes and type 2 diabetes in adulthood: the Bogalusa Heart Study. Arch Pediatr Adolesc Med. 2010, 164 (2): 124-128. 10.1001\/archpediatrics.2009.268.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"618_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.mcna.2010.11.003","volume":"95","author":"S Colagiuri","year":"2011","unstructured":"Colagiuri S: Epidemiology of prediabetes. Med Clin North Am. 2011, 95 (2): 299-307. 10.1016\/j.mcna.2010.11.003.","journal-title":"Med Clin North Am"},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2147\/VHRM.S11681","volume":"6","author":"C Voulgari","year":"2010","unstructured":"Voulgari C, Papadogiannis D, Tentolouris N: Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag. 2010, 6: 883-903.","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"618_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED: Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord. 2010, 11 (1): 31-39. 10.1007\/s11154-010-9131-7.","journal-title":"Rev Endocr Metab Disord"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990, 322: 1561-1566. 10.1056\/NEJM199005313222203.","journal-title":"N Engl J Med"},{"issue":"12","key":"618_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cardfail.2010.07.249","volume":"16","author":"S Murarka","year":"2010","unstructured":"Murarka S, Movahed MR: Diabetic cardiomyopathy. J Card Fail. 2010, 16 (12): 971-979. 10.1016\/j.cardfail.2010.07.249.","journal-title":"J Card Fail"},{"key":"618_CR14","first-page":"59","volume":"4","author":"S Nunes","year":"2012","unstructured":"Nunes S, Soares E, Pereira FC, Reis F: The role of inflammation in diabetic cardiomyopathy. Int J Infereron Cytokine Mediator Res. 2012, 4: 59-73.","journal-title":"Int J Infereron Cytokine Mediator Res"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1475-2840-11-57","volume":"11","author":"S Fredersdorf","year":"2012","unstructured":"Fredersdorf S, Thumann C, Zimmermann WH, Vetter R, Graf T, Luchner A, Riegger GA, Schunkert H, Eschenhagen T, Weil J: Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data. Cardiovasc Diabetol. 2012, 11: 57-10.1186\/1475-2840-11-57.","journal-title":"Cardiovasc Diabetol"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1475-2840-11-126","volume":"11","author":"L Hou","year":"2012","unstructured":"Hou L, Lian K, Yao M, Shi Y, Lu X, Fang L, He T, Jiang L: Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart. Cardiovasc Diabetol. 2012, 11: 126-10.1186\/1475-2840-11-126.","journal-title":"Cardiovasc Diabetol"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1475-2840-11-129","volume":"11","author":"M Aragno","year":"2012","unstructured":"Aragno M, Mastrocola R, Gh\u00e9 C, Arnoletti E, Bassino E, Alloatti G, Muccioli G: Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc Diabetol. 2012, 11: 129-10.1186\/1475-2840-11-129.","journal-title":"Cardiovasc Diabetol"},{"issue":"9\u201310","key":"618_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1242\/dmm.001941","volume":"2","author":"H Bugger","year":"2009","unstructured":"Bugger H, Abel ED: Rodent models of diabetic cardiomyopathy. Dis Model Mech. 2009, 2 (9\u201310): 454-466.","journal-title":"Dis Model Mech"},{"key":"618_CR19","first-page":"R1319","volume":"271","author":"MJ Pagliassotti","year":"1996","unstructured":"Pagliassotti MJ, Prach PA, Koppenhafer TA, Pan DA: Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol. 1996, 271: R1319-R1326.","journal-title":"Am J Physiol"},{"issue":"2","key":"618_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/sj.bjp.0704864","volume":"137","author":"M Santur\u00e9","year":"2002","unstructured":"Santur\u00e9 M, Pitre M, Marette A, Deshaies Y, Lemieux C, Larivi\u00e8re R, Nadeau A, Bachelard H: Induction of insulin resistance by high-sucrose feeding does not raise mean arterial blood pressure but impairs haemodynamic responses to insulin in rats. Br J Pharmacol. 2002, 137 (2): 185-196. 10.1038\/sj.bjp.0704864.","journal-title":"Br J Pharmacol"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8: e1000412-10.1371\/journal.pbio.1000412.","journal-title":"PLoS Biol"},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985, 28: 412-419. 10.1007\/BF00280883.","journal-title":"Diabetologia"},{"issue":"1","key":"618_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"P Smith","year":"1985","unstructured":"Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M, Fujimoto E, Goeke N, Olson B, Klenk D: Measurement of protein using bicinchoninic acid. Anal Biochem. 1985, 150 (1): 76-85. 10.1016\/0003-2697(85)90442-7.","journal-title":"Anal Biochem"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12012-009-9054-2","volume":"9","author":"N Piloto","year":"2009","unstructured":"Piloto N, Teixeira HM, Teixeira-Lemos E, Parada B, Garrido P, Sereno J, Pinto R, Carvalho L, Costa E, Belo L, Santos-Silva A, Teixeira F, Reis F: Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping. Cardiovasc Toxicol. 2009, 9: 201-210. 10.1007\/s12012-009-9054-2.","journal-title":"Cardiovasc Toxicol"},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/0975-7406.92743","volume":"4","author":"M Teixeira","year":"2012","unstructured":"Teixeira M, Rodrigues-Santos P, Garrido P, Costa E, Parada B, Sereno J, Alves R, Belo L, Teixeira F, Santos-Silva A, Reis F: Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat. J Pharm Bioallied Sci. 2012, 4: 76-83. 10.4103\/0975-7406.92743.","journal-title":"J Pharm Bioallied Sci"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real -time quanti-tative PCR and the 2-\u0394\u0394CT. Method Methods. 2001, 25: 402-408. 10.1006\/meth.2001.1262.","journal-title":"Method Methods"},{"issue":"5","key":"618_CR27","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s00125-005-1714-6","volume":"48","author":"RT Ribeiro","year":"2005","unstructured":"Ribeiro RT, Lautt WW, Legare DJ, Macedo MP: Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia. 2005, 48 (5): 976-983. 10.1007\/s00125-005-1714-6.","journal-title":"Diabetologia"},{"issue":"3","key":"618_CR28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jn\/136.3.582","volume":"136","author":"M Sumiyoshi","year":"2006","unstructured":"Sumiyoshi M, Sakanaka M, Kimura Y: Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr. 2006, 136 (3): 582-587.","journal-title":"J Nutr"},{"issue":"1","key":"618_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbalip.2004.12.003","volume":"1733","author":"Ghafoorunissa","year":"2005","unstructured":"Ghafoorunissa , Ibrahim A, Natarajan S: Substituting dietary linoleic acid with alpha-linolenic acid improves insulin sensitivity in sucrose fed rats. Biochim Biophys Acta. 2005, 1733 (1): 67-75. 10.1016\/j.bbalip.2004.12.003.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"618_CR30","doi-asserted-by":"crossref","first-page":"R1334","DOI":"10.1152\/ajpregu.2000.279.4.R1334","volume":"279","author":"JS Thresher","year":"2000","unstructured":"Thresher JS, Podolin DA, Wei Y, Mazzeo RS, Pagliassotti MJ: Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance. Am J Physiol Regul Integr Comp Physiol. 2000, 279 (4): R1334-R1340.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"618_CR31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ajcn\/38.6.879","volume":"38","author":"D Wright","year":"1983","unstructured":"Wright D, Hansen R, Mondon C, Reaven G: Sucrose-induced insulin resistance in the rat: modulation by exercise and diet. Am J Clin Nutr. 1983, 38: 879-883.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"618_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ilar.47.3.186","volume":"47","author":"WT Cefalu","year":"2006","unstructured":"Cefalu WT: Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR J. 2006, 47 (3): 186-198. 10.1093\/ilar.47.3.186.","journal-title":"ILAR J"},{"issue":"11","key":"618_CR33","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.2337\/db11-0549","volume":"60","author":"Y Ti","year":"2011","unstructured":"Ti Y, Xie GL, Wang ZH, Bi XL, Ding WY, Wang J, Jiang GH, Bu PL, Zhang Y, Zhong M, Zhang W: TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model. Diabetes. 2011, 60 (11): 2963-2974. 10.2337\/db11-0549.","journal-title":"Diabetes"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1301\/nr.2003.may.S27-S33","volume":"61","author":"M Kanazawa","year":"2003","unstructured":"Kanazawa M, Xue CY, Kageyama H, Suzuki E, Ito R, Namba Y, Osaka T, Kimura S, Inoue S: Effects of a high-sucrose diet on body weight, plasma triglycerides, and stress tolerance. Nutr Rev. 2003, 61: S27-S33. 10.1301\/nr.2003.may.S27-S33.","journal-title":"Nutr Rev"},{"key":"618_CR35","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/jn\/134.8.1942","volume":"134","author":"T Suzuki","year":"2004","unstructured":"Suzuki T, Hara H: Ingestion of guar gum hydrolysate, a soluble and fermentable nondigestible saccharide, improves glucose intolerance and prevents hypertriglyceridemia in rats fed fructose. J Nutr. 2004, 134: 1942-1947.","journal-title":"J Nutr"},{"key":"618_CR36","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1006\/jmcc.2000.1197","volume":"32","author":"S Chen","year":"2000","unstructured":"Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S: Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J Mol Cell Cardiol. 2000, 32: 1621-1629. 10.1006\/jmcc.2000.1197.","journal-title":"J Mol Cell Cardiol"},{"key":"618_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1475-2840-11-73","volume":"11","author":"CJ Li","year":"2012","unstructured":"Li CJ, Lv L, Li H, Yu DM: Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol. 2012, 11: 73-10.1186\/1475-2840-11-73.","journal-title":"Cardiovasc Diabetol"},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"E1089","DOI":"10.1152\/ajpendo.00540.2002","volume":"284","author":"S Chen","year":"2003","unstructured":"Chen S, Khan ZA, Cukiernik M, Chakrabarti S: Differential activation of NF-_B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab. 2003, 284: E1089-E1097.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"618_CR39","doi-asserted-by":"publisher","first-page":"E1119","DOI":"10.1152\/ajpendo.00029.2008","volume":"294","author":"B Feng","year":"2008","unstructured":"Feng B, Chen S, Chiu J, George B, Chakrabarti S: Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab. 2008, 294 (6): E1119-E1126. 10.1152\/ajpendo.00029.2008.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"618_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis N: The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007, 74 (2): 184-195. 10.1016\/j.cardiores.2006.10.002.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"618_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/jcp.46.1.32","volume":"46","author":"M Shimizu","year":"1993","unstructured":"Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I: Collagen remodelling in myocardial of patients with diabetes. J Clin Pathol. 1993, 46 (1): 32-36. 10.1136\/jcp.46.1.32.","journal-title":"J Clin Pathol"},{"issue":"8","key":"618_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1161\/01.CIR.101.8.899","volume":"101","author":"K Mizushige","year":"2000","unstructured":"Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H: Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 2000, 101 (8): 899-907. 10.1161\/01.CIR.101.8.899.","journal-title":"Circulation"},{"issue":"3","key":"618_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/db06-1163","volume":"56","author":"D Westermann","year":"2007","unstructured":"Westermann D, Rutschow S, Jager S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tsch\u00f6pe C: Contributions of inflammation and cardiac matrix metallopro-teinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes. 2007, 56 (3): 641-646. 10.2337\/db06-1163.","journal-title":"Diabetes"},{"issue":"1","key":"618_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1582-4934.2002.tb00307.x","volume":"6","author":"J Lawler","year":"2002","unstructured":"Lawler J: Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med. 2002, 6 (1): 1-12. 10.1111\/j.1582-4934.2002.tb00307.x.","journal-title":"J Cell Mol Med"},{"key":"618_CR45","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/ndt\/gfl017","volume":"21","author":"S Yung","year":"2006","unstructured":"Yung S, Lee CYY, Zhang Q, Lau SK, Tsang RCW, Chan TM: Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-b1 dependent and TGF-b1 independent pathways. Nephrol Dial Transplant. 2006, 21: 1504-1513. 10.1093\/ndt\/gfl017.","journal-title":"Nephrol Dial Transplant"},{"key":"618_CR46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11926-002-0009-x","volume":"4","author":"A Leask","year":"2002","unstructured":"Leask A, Holmes A, Abraham DJ: Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Reumatol Rep. 2002, 4: 136-142. 10.1007\/s11926-002-0009-x.","journal-title":"Curr Reumatol Rep"},{"key":"618_CR47","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2337\/diabetes.51.9.2709","volume":"51","author":"KJ Way","year":"2002","unstructured":"Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, King GL: Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes. 2002, 51: 2709-2718. 10.2337\/diabetes.51.9.2709.","journal-title":"Diabetes"},{"issue":"3","key":"618_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejheart.2004.01.004","volume":"6","author":"M Vanderheyden","year":"2004","unstructured":"Vanderheyden M, Bartunek J, Goethals M: Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail. 2004, 6 (3): 261-268. 10.1016\/j.ejheart.2004.01.004.","journal-title":"Eur J Heart Fail"},{"key":"618_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2840-9-89","volume":"9","author":"S Romano","year":"2010","unstructured":"Romano S, Di Mauro M, Fratini S, Guarracini L, Guarracini F, Poccia G, Penco M: Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides. Cardiovasc Diabetol. 2010, 9: 89-10.1186\/1475-2840-9-89.","journal-title":"Cardiovasc Diabetol"},{"key":"618_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1475-2840-8-43","volume":"8","author":"BE Reinking","year":"2009","unstructured":"Reinking BE, Wedemeyer EW, Weiss RM, Segar JL, Scholz TD: Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways. Cardiovasc Diabetol. 2009, 8: 43-10.1186\/1475-2840-8-43.","journal-title":"Cardiovasc Diabetol"},{"key":"618_CR51","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1161\/01.CIR.102.23.2873","volume":"102","author":"R Aikawa","year":"2000","unstructured":"Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, Nagai R, Komuro I: Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase\/Akt. Circulation. 2000, 102: 2873-2879. 10.1161\/01.CIR.102.23.2873.","journal-title":"Circulation"},{"key":"618_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1874192401105010153","volume":"5","author":"SS Soski\u0107","year":"2011","unstructured":"Soski\u0107 SS, Branislava DD, Sudar EM, Obradovi\u0107 MM, Nikoli\u0107 DM, Djordjevic JD, Radak DJ, Mikhailidis DP, Isenovi\u0107 ER: Regulation of Inducible Nitric Oxide Synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J. 2011, 5: 153-163. 10.2174\/1874192401105010153.","journal-title":"Open Cardiovasc Med J"},{"key":"618_CR53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2337\/db12-0339","volume":"62","author":"ER Ropelle","year":"2013","unstructured":"Ropelle ER, Pauli JR, Cintra DE, da Silva AS, De Souza CT, Guadagnini D, Carvalho BM, Caricilli AM, Katashima CK, Carvalho-Filho MA, Hirabara S, Curi R, Velloso LA, Saad MJ, Carvalheira JB: Targeted disruption of inducible nitric oxide synthase protects against aging, s-nitrosation, and insulin resistance in muscle of male mice. Diabetes. 2013, 62: 466-470. 10.2337\/db12-0339.","journal-title":"Diabetes"},{"key":"618_CR54","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1073\/pnas.97.4.1784","volume":"97","author":"YT Zhou","year":"2000","unstructured":"Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH: Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA. 2000, 97: 1784-1789. 10.1073\/pnas.97.4.1784.","journal-title":"Proc Natl Acad Sci USA"},{"key":"618_CR55","doi-asserted-by":"publisher","first-page":"C327","DOI":"10.1152\/ajpcell.00254.2008","volume":"296","author":"JH Lee","year":"2009","unstructured":"Lee JH, Palaia T, Ragolia L: Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am J Physiol Cell Physiol. 2009, 296: C327-C338.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"618_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0953-6205(02)00014-6","volume":"13","author":"EB Jude","year":"2002","unstructured":"Jude EB, Douglas JT, Anderson SG, Young MJ, Boulton AJ: Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. Eur J Intern Med. 2002, 13 (3): 185-189. 10.1016\/S0953-6205(02)00014-6.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"618_CR57","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jdiacomp.2005.06.005","volume":"20","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu SS, Chaturvedi N, Schalkwijk CG, Stehouwer CD, Ebeling P, Fuller JH, EURODIAB Prospective Complications Study group: Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients. J Diabetes Complications. 2006, 20 (3): 188-195. 10.1016\/j.jdiacomp.2005.06.005.","journal-title":"J Diabetes Complications"},{"key":"618_CR58","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","volume":"39","author":"DO Bates","year":"2002","unstructured":"Bates DO, Harper SJ: Regulation of vascular permeability by vascular endothelial growth factors. Vasc Pharmacol. 2002, 39: 225-237. 10.1016\/S1537-1891(03)00011-9.","journal-title":"Vasc Pharmacol"},{"key":"618_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/157339906775473671","volume":"2","author":"R Sim\u00f3","year":"2006","unstructured":"Sim\u00f3 R, Carrasco E, Garcia-Ramirez M, Hernandez C: Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006, 2: 71-98. 10.2174\/157339906775473671.","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"618_CR60","doi-asserted-by":"publisher","first-page":"e16239","DOI":"10.1371\/journal.pone.0016239","volume":"6","author":"XY Yu","year":"2011","unstructured":"Yu XY, Chen HM, Liang JL, Lin QX, Tan HH, Fu YH, Liu XY, Shan ZX, Li XH, Yang HZ, Yang M, Li Y, Li SG: Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor. PLoS One. 2011, 6 (1): e16239-10.1371\/journal.pone.0016239.","journal-title":"PLoS One"},{"issue":"7","key":"618_CR61","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1253\/circj.CJ-10-1199","volume":"75","author":"Y Mano","year":"2011","unstructured":"Mano Y, Anzai T, Kaneko H, Nagatomo Y, Nagai T, Anzai A, Maekawa Y, Takahashi T, Meguro T, Yoshikawa T, Fukuda K: Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Circ J. 2011, 75 (7): 1717-1727. 10.1253\/circj.CJ-10-1199.","journal-title":"Circ J"},{"issue":"10","key":"618_CR62","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00125-006-0385-2","volume":"49","author":"D Westermann","year":"2006","unstructured":"Westermann D, Rutschow S, Van Linthout S, Linderer A, B\u00fccker-G\u00e4rtner C, Sobirey M, Riad A, Pauschinger M, Schultheiss HP, Tsch\u00f6pe C: Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus. Diabetologia. 2006, 49 (10): 2507-2513. 10.1007\/s00125-006-0385-2.","journal-title":"Diabetologia"},{"issue":"5","key":"618_CR63","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/01.CIR.95.5.1247","volume":"95","author":"T Yokoyama","year":"1997","unstructured":"Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman ML, Mann DL: Tumor necrosis factor-\u03b1provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997, 95 (5): 1247-1252. 10.1161\/01.CIR.95.5.1247.","journal-title":"Circulation"},{"issue":"20","key":"618_CR64","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1161\/01.CIR.0000147233.10318.23","volume":"110","author":"M Sun","year":"2004","unstructured":"Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA, Liu PP: Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation. 2004, 110 (20): 3221-3228. 10.1161\/01.CIR.0000147233.10318.23.","journal-title":"Circulation"},{"key":"618_CR65","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/cvr\/cvq102","volume":"87","author":"CW Younce","year":"2010","unstructured":"Younce CW, Wang K, Kolattukudy PE: Hyperglycemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. Cardiovas Res. 2010, 87: 665-674. 10.1093\/cvr\/cvq102.","journal-title":"Cardiovas Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-12-44.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:38:25Z","timestamp":1630535905000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-12-44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,7]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-12-44","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,7]]},"assertion":[{"value":"11 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"44"}}